French multinational pharmaceutical and healthcare company Sanofi announced a partnership with New York-based TrialSpark, which offers a technology-based model for drug development.
TrialSpark's tools aim for more efficient trial design, faster trial completion and higher quality trial data. It acquires clinical-stage drugs from pharmaceutical and biotech companies and develops them using its...
Global investment firm Francisco Partners, which partners with technology businesses, announced that it has signed a definitive agreement to acquire bswift from CVS Health for an undisclosed amount.
The acquisition is expected to close in the fourth quarter, subject to the satisfaction of standard closing conditions.
bswift was founded in 1996, and has since provided software and services to help...
Acurable, a U.K.-based medical device company, announced it raised €11 million ($10.8 million) in a Series A funding round led by Kibo Ventures. Mundi Ventures, Comprador Holdings and Kindred Capital participated in the raise.
The company will use the funds to accelerate the international expansion of its first home sleep-testing device, the AcuPebble SA100, which enables users to detect and...
New York-based Grow Therapy, which offers mental health providers tools to help them start their private practice and be covered by insurance, has raised $75 million in Series B funding.
The round was led by TCV and Transformation Capital, and supported by existing investors SignalFire and SVB.
The funds will be used to expand the company's insurance coverage, improve its offerings and build its...
The J.D. Power 2022 U.S. Telehealth Satisfaction Study released today shows a stark increase in consumers preferring telehealth visits over in-person appointments for a broad range of routine care.
The study finds that 67% of survey respondents relayed they have accessed video telehealth services during the past year. Before the pandemic in 2019, that number was 37%.
Among those who used...
Rippl, a company focused on providing mental health solutions to seniors with dementia and other cognitive conditions, launched with a $32 million seed round led by ARCH Venture Partners and General Catalyst.
GV, F-Prime Capital and Mass General Brigham Ventures also participated.
WHAT THEY DO
The company, led by Starbucks veteran Kris Engskov, said it will launch a care model offered by health...
XP Health, a company developing a digital-first vision benefits platform, raised $17.1 million in a Series A funding round led by HC9 Ventures, Valor Capital Group and ManchesterStory.
Additional investors include Core Innovation Capital, GSR Ventures, Canvas Ventures, Plug and Play, CameronVC, Ken Goulet, Kevin Hill, Jeff Epstein and Brett Rochkind. This recent funding round followed a $5.5...
This week Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies like AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund and Amazon Web Services, announced the formation of a new startup company dubbed OMEC.AI.
OMEC.AI aims to build a computational platform using AI that can help researchers assess the clinical trial readiness of a drug...
Calif.-based DyAnsys, a medical device company specializing in the autonomous nervous system, announced Primary Relief, its percutaneous electrical nerve stimulator (PENS) system, received approval by the FDA to treat postoperative pain following cardiac surgery.
According to DyAnsys, the PENS system can be used for up to three days following cardiac surgery and, in a clinical trial, reduced...
Australian company Seer Medical received FDA 510(k) clearance for its at-home electroencephalograph (EEG) system, Seer Home, which helps providers diagnose epilepsy.
Seer Home’s EEG system enables patients to undergo week-long studies at home. Patients wear a device – the Seer Sense – around their shoulders with electrodes connected to the patient’s skull and chest to record brain (EEG) and...
_8_43.jpeg?itok=smxgAxmM "A piggy bank next to a stethoscope and a pile of coins.")
